Risk factors for rifampicin-susceptible and isoniazid-resistant tuberculosis in adult patients with type 2 diabetes mellitus in Nanjing
Abstract Objective Globally, Tuberculosis(TB) with type 2 diabetes mellitus (T2DM) is becoming increasingly serious, especially the emergence of rifampicin-susceptible and isoniazid-resistant tuberculosis (Hr-TB), which increases the difficulty of treatment and the burden of disease. Therefore, this...
Saved in:
| Main Authors: | Jing Guo, Xuebing Feng, Jialei Pang, Wenchao Li, Min Cai, Zhiyun Cao, Feishen Lin, Xia Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-10709-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01) -
Rectal Administration of Rifampicin and Isoniazid Suppositories: An Alternative Approach for the Treatment of Tuberculosis in a Patient with Multiple Comorbidities
by: Ioana Munteanu, et al.
Published: (2025-05-01) -
Relapse of Pulmonary Tuberculosis in Patients with Resistance to Isoniazid
by: I. A. Burmistrova, et al.
Published: (2023-07-01) -
Use of Dispersible Fixed-Dose Combinations in Chemotherapy of Drug Susceptible Tuberculosis: Results of the Observational Study
by: E. S. Nikitina, et al.
Published: (2024-10-01) -
Is a 6-month Treatment for Isoniazid-resistant Tuberculosis Effective?
by: A. I. Kulizhskaya, et al.
Published: (2022-03-01)